TFRC Knockout HEK293 Cell Line
Cat.No.:
EDC08077
Species:
Human
Cell Name:
HEK293
Gene:
TFRC
Gene ID:
7037
Size:
1×10⁶cells
TFRC Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08077 |
|---|---|
| Product Name | TFRC Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | TFRC |
| NCBI Gene ID | |
| Gene Synonyms | CD71|IMD46|T9|TFR|TFR1|TR|TRFR|p90 |
| Summary |
This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying TFRC function, TFRC Knockout HEK293 Cell Line or TFRC overexpression HEK293 Cell Line?
The choice depends on whether you are studying iron uptake biology, transferrin endocytosis, or using TFRC as a model receptor for clathrin-mediated endocytosis research. The Knockout line is the standard tool for asking whether TFRC is required for transferrin-mediated iron uptake — TFRC is the principal iron uptake receptor in most cell types and is essential for proliferating cells. Overexpression is useful for studying TFRC trafficking dynamics or for boosting iron uptake capacity.
Important consideration: TFRC is essential in most proliferating cells — complete knockout may significantly impair viability and proliferation. The EDITGENE Knockout in HEK293 may exhibit reduced growth that should be characterized before extended use. Rescue with wild-type or endocytosis-deficient (cytoplasmic tail mutant) TFRC enables dissection of iron uptake from endocytic membrane trafficking functions. TFRC is also being explored as an antibody-drug conjugate target — the knockout serves as a critical specificity control for anti-TFRC therapeutics.
What are the application scenarios for this model?
Primary applications:
• Iron uptake assays: ⁵⁹Fe or fluorescent iron sensor measurements of transferrin-mediated iron uptake in the absence of TFRC.
• Endocytosis studies: TFRC has long served as a model for clathrin-mediated endocytosis — fluorescent transferrin uptake kinetics characterize endocytic pathway integrity.
• Anti-TFRC ADC validation: TFRC is a target for antibody-drug conjugates targeting proliferating cells; the knockout serves as a critical specificity control.
• Viability and proliferation: TFRC is essential in most proliferating cells; characterization of growth phenotypes informs experimental design.
EDITGENE recommends this model for researchers investigating iron homeostasis, clathrin-mediated endocytosis mechanisms, and TFRC-targeting therapeutics.
Is this TFRC Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. TFRC rescue experiments require attention to essentiality and endocytic function:
• Construct design: use a codon-modified TFRC sequence with a C-terminal tag (FLAG, HA). TFRC is a type II membrane protein — N-terminal cytoplasmic tag is preferred over interfering with the extracellular transferrin-binding domain.
• Viability considerations: TFRC is essential for proliferating cells; rescue experiments may need to be timed before significant proliferation defects accumulate.
• Endocytosis-deficient rescue: cytoplasmic tail mutations (e.g., Y20A, internalization motif disruption) separate iron uptake from endocytic membrane trafficking functions.
• Functional readout: rescue should restore transferrin binding (flow cytometry with fluorescent transferrin) and iron uptake capacity.
HEK293 transduces efficiently with lentivirus, though rescue should be initiated promptly given TFRC's essential role in proliferation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download